Skip to main content
Premium Trial:

Request an Annual Quote

Sabatini on Leave

David Sabatini has been placed on leave by Massachusetts Institute of Technology following a sexual harassment investigation, the Boston Globe reports. It adds that Sabatini is also no longer associated with MIT's Whitehead Institute, where he ran a lab, or the Howard Hughes Medical Institute, which funded his work, and could have his tenure revoked.

A recent Diversity, Equity, and Inclusion survey uncovered concerning issues with the Sabatini lab that prompted MIT to hire an outside law firm to investigate, the Globe reports. That investigation found that Sabatini violated the Whitehead's policies on sexual harassment. The report "raises very serious concerns about sexual and workplace harassment," Nergis Mavalvala, the dean of the MIT School of Science, wrote in a letter to biology faculty Friday, according to the Globe.

An MIT spokesperson additionally tells Science. That the "senior administration is reviewing the report and determining next steps in response to these findings, up to and including revocation of tenure proceedings."

Science adds that Sabatini's lab, which studies pathways regulating growth and metabolism in mammals, includes 39 people and that MIT human resources personnel are to help them into other roles. Sabatini also co-founded KSQ Therapeutics and Raze Therapeutics, the Globe says.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.